Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Helus Pharma Inc. and every other company we cover.
Try it first on NVDA, AAPL, META, NKE or CAKE, where it is open to everyone.
$8.86-5.6%Nov 12 close
Reported results on November 12, 2026; they are not in these figures yet.
Figures through March 31, 2026, from the 40-F filed June 29, 2026